Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alphabet
2
×
biotech
boston blog main
boston top stories
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
verily
abbvie
ac immune
acquisition
alliances
american hpspital association
american medical association
atlas ventures
bacteriophage
baseline
bioscicience
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
broad institute of harvard and mit
brook byers
car-t chimeric antigen receptor
cd39
celgene
ceo
charles chu
chris lowe
cmo
commissioner
cortexyme
crispr
crispr cas14
crispr-cas3
cso
cydan
deals
What
bio
2
×
available
based
big
biopharma
biosciences
car
cas
celgene
cheaper
colleagues
crispr
develop
diagnostics
exome
expects
faster
government
health
hundreds
industry
mammoth
medicine
policy
published
ready
roundup
set
sf
stories
tales
things
tiny
today
what’s
Language
unset
Current search:
alphabet
×
bio
×
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
